Keenova Therapeutics plc Business Acquisition, Pro Forma Earnings Per Share, Basic
Keenova Therapeutics plc reported Business Acquisition, Pro Forma Earnings Per Share, Basic of $4.52 per share for the 12-month period ending 2016-09-30, per its 10-K filed 2016-11-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic · last filed 2016-11-29
- Keenova Therapeutics plc business acquisition, pro forma earnings per share, basic for the quarter ending 2015-06-26 was $0.70, a 32.08% increase year-over-year.
- Keenova Therapeutics plc business acquisition, pro forma earnings per share, basic for the quarter ending 2014-06-27 was $0.53.
- Keenova Therapeutics plc business acquisition, pro forma earnings per share, basic for fiscal 2016 was $4.52, a 81.53% increase from fiscal 2015.
- Keenova Therapeutics plc business acquisition, pro forma earnings per share, basic for fiscal 2015 was $2.49.
- Keenova Therapeutics plc business acquisition, pro forma earnings per share, basic for fiscal 2014 was -$0.55.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Basic 3 month | Business Acquisition, Pro Forma Earnings Per Share, Basic 9 month | Business Acquisition, Pro Forma Earnings Per Share, Basic 12 month | Business Acquisition, Pro Forma Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|
| 2016-09-30 | $4.52 10-K · filed 2016-11-29 | |||
| 2015-09-25 | $2.49 10-K · filed 2016-11-29 | $3.11 10-K · filed 2015-11-24 | ||
| 2015-06-26 | $0.70 10-Q · filed 2015-08-04 | $2.29 10-Q · filed 2015-08-04 | ||
| 2014-09-26 | -$0.55 10-K · filed 2015-11-24 | |||
| 2014-06-27 | $0.53 10-Q · filed 2015-08-04 | $0.93 10-Q · filed 2015-08-04 |